Know Cancer

or
forgot password

Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging


N/A
N/A
N/A
Not Enrolling
Both
Bladder Cancer, Transitional Cell Carcinoma

Thank you

Trial Information

Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging


Inclusion Criteria:



- Thirty (30) patients will be enrolled in this pilot study.

- All patients will have a clinical or histologic diagnosis of bladder cancer with
active disease identified within the bladder at the time of consent and imaging.

- Patients with primary resectable lesions, and localized or regionally extensive
disease will be eligible with residual disease in the bladder at the time of imaging.

- All patients will have consented to treatment at MSKCC

Exclusion Criteria:

- Prior pelvic radiation for bladder cancer

- Non-transitional cell histologies

- Patients deemed not appropriate surgical candidates

- Patients that are pregnant or lactating

- Patients that cannot tolerate being in the PET or MRI scanner for the duration of the
study. Patients deemed unable to receive a contrast enhance CT will remain eligible.

- Vulnerable patients (minors, mentally retarded, prisoners, etc.)

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Evaluate the logistical and technical parameters that are needed to use 11C acetate-PET, and MRI for the preoperative detection of nodal metastases in patients with invasive bladder cancer.

Outcome Time Frame:

conclusion of the study

Safety Issue:

No

Principal Investigator

Bernard Bochner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

03-024

NCT ID:

NCT00612326

Start Date:

June 2004

Completion Date:

March 2008

Related Keywords:

  • Bladder Cancer
  • Transitional Cell Carcinoma
  • Urinary Bladder Neoplasms
  • Carcinoma
  • Carcinoma, Transitional Cell

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021